ID-EPTRI development of project towards a medical application services

Provided by ID-EPTRI

EPTRI

EPTRI provides integrated services provided by the Thematic Research Platforms in EPTRI in the following fields:
1. Paediatric Medicines Discovery
2. Paediatric Biomarkers and Biosamples
3. Developmental Pharmacology
4. Paediatric Medicines Formulations

Visit website

SOLVE-RD development of project towards a medical application services

Provided by SOLVE-RD

Rare Diseases Models & Mechanisms – Europe (RDMM-Europe): This brokerage service will catalyse connections between people discovering new genes in rare disease patients and basic scientists who can study those genes and pathways in model organisms. Solve-RD brokerage service are to:
*provide functional validation of human genetic variants that cause disease;
*supplement clinical disease gene discoveries by generating functional data so as to get higher impact publications;
*develop insights into potential rationale for treatment (e.g. identification of candidate drug targets) via knowledge of a disease gene pathway; and
*establish longer term collaborations between basic scientists and clinicians that will lead to subsequent grant funding in support of outstanding basic and/or applied research

Visit website

CIDSTEM – INTERDEPARTMENTAL CENTRE FOR STEM CELLS AND REGENERATIVE MEDICINE development of project towards a medical application services

Provided by CIDSTEM - INTERDEPARTMENTAL CENTRE FOR STEM CELLS AND REGENERATIVE MEDICINE

CIDSTEM has a GMP-authorized facility for the implementation of advanced therapies and the technical and professional skills to manage the GMP laboratory and clinical trials of these therapies.
It therefore possesses the know-how and instrumentation necessary to offer companies:
-an implementation service for research and clinical trials, approved by regulatory bodies, of advanced therapies involving cell cultures in GMP;
-A consulting service for the technological transfer of clinical and preclinical trials in GMP and for the production of cell cultures for advanced therapies.
-An implementation service of research aimed at the industrialization of cell cultures for the development of ATMPs;
-a testing service of new technologies (nanomaterials, scaffolds for the realization of 3D cellular tissues, laboratory equipment, software for clinical trials and for the management of biological data, GMP compliant logistics, etc.).

Translated with www.DeepL.com/Translator (free version)

Visit website

EATRIS – EUROPEAN INFRASTRUCTURE FOR TRANSLATIONAL MEDICINE development of project towards a medical application services

Provided by EATRIS – EUROPEAN INFRASTRUCTURE FOR TRANSLATIONAL MEDICINE

EATRIS

Within the EJP RD, EATRIS offers an expert mentoring service for rare disease researchers. Advancing promising technologies and therapies towards clinical application is a complex undertaking. Academic research often lacks easy access to regulatory, therapy development expertise, manufacturing, and healthcare practice, leading to high failure rates. The menotirng prgrammes prvides menotirng on
Translational feasibility
Regulatory compliance
Product classification
Quality assurance and control
Intellectual property strategy
Suitability of analytical readouts
Manufacturing
Therapy development

Visit website

ORPHANET development of project towards a medical application services

Provided by ORPHANET

Orphanet provides information on professionals whose activity(ies) in the field of rare diseases is (are) registered in Orphanet. This includes, for example, consultant and physicians in charge of an expert centre, biologists in a laboratory, researchers, representatives of patient organisations, coordinators of networks, principal investigators of clinical trials, managers or contact person of registries and biobanks, and experts writing or peer-reviewing data for Orphanet.

Visit website